What is Xiidra?
Xiidra is a prescription eye drops used in the treatment and signs and symptoms of dry eye disease (DED). It comes in the form of a 5% ophthalmic solution, or eye drop, that is instilled into each eye. Xiidra, or lifitegrast ophthalmic solution, helps block inflammatory processes in the eye that can contribute to redness and dryness in the eyes. As a result, it helps reduce inflammation in the eye tissues, among other symptoms of DED.
Xiidra Eye Drops Information
Xiidra is used to treat moderate to severe dry eye disease in adults. It is often prescribed when artificial tears are not sufficient for those with dry eye disease. It contains the active ingredient lifitegrast.
It is a twice-a-day eye drop manufactured by Shire to help alleviate dryness and inflammation in the eyes. Signs and symptoms of dry eye disease include irritation, inflammation, and blurry vision.
It is typically administered twice daily with about 12 hours in between doses. Consult a healthcare provider for the proper dose as it may depend on the condition being treated.
Xiidra is classified as a lymphocyte function-associated antigen-1 (LFA-1). It works by blocking certain molecules called LFA-1 and ICAM-1 from interacting. The exact way in which it works is not completely known. However, it has been shown to help relieve the signs and symptoms of dry eye disease.
Tell your doctor if you are using other eye drops before using Xiidra to avoid an allergic reaction. You should also tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding before using this medication.
If you wear contact lenses remove them prior to administering the medicine. The contact lenses should not be replaced until 15 minutes after administering the eye drop. Talk to your doctor about how to store and administer the medication.
Always read and understand the important safety information provided with the product before you begin treatment. When you buy Xiidra online from Your Canada Drug Store, we always send the products in the manufacturer’s packaging.
It is typically administered in both eyes twice daily, usually 12 hours apart. It should be used immediately after opening. No leftover solution should be saved for later use. Do not touch the tip of the dropper on surfaces or your eye.
Seek immediate medical attention if you experience wheezing, difficulty breathing, or swelling of the face, lips, or throat.
After the application of the drug you may have reduced visual acuity. Avoid using vehicles, tools or heavy machinery until you understand how this affects your vision.
- eye Irritation
- Altered taste in the mouth
- Blurred vision
This is not a complete list of potential side effects. Report side effects to your doctor. If you find them unmanageable call your doctor for medical advice about side effects. We also have a pharmacist that can provide counselling when you buy Xiidra online.
Xiidra 5% Ophthalmic Solution cost in Canada starts from $5.02 per vials and it's manufactured by Shire in Canada. 180 vials costs $903.99 and you can pay this in 4 interest-free payments of $226. You will only pay $226 and place the order.
Use XIIYCD2005 and get $5 OFF when you buy Xiidra online, add this coupon at the cart page.
Xiidra Eye Drops FAQs
Xiidra does not cure dry eye syndrome, instead, it is used to alleviate its symptoms. How it reduces burning, stinging, and redness caused by inflammation is what provides relief for those with dry eyes. It will only treat the occurring symptoms of the disease and once the medication is stopped, the symptoms often return.
Xiidra can cause headaches, although it usually isn't listed as a common side effect. Clinical studies show its occurrence in patients was only between 1-5% percent. If headaches do not subside or occur too often, talk to your doctor to reevaluate your treatment.
The manufacture of Xiidra by Shire US Inc. in 2016. Takeda Pharmaceuticals acquired these rights in January of 2019. In July of 2019, it was once again acquired by another company. It is currently marketed under Novartis. The production of its generic ingredient lifitegrast is supplied by both Novartis Pharmaceuticals corporation and Shire US Manufacturing.
Xiidra and Restasis are both effective in the treatment of dry eyes. They both reduce inflammation present in dry eyes syndrome. Although they belong to different drug classes, Restasis is an immunosuppressive agent unlike Xiidra that is a LFA-1 antagonist.
If the concern is with its side effects, it may cause an unusual taste sensation in 5-25% of patients. But if you want a faster onset of action, Restasis may take three months while Xiidra will take only two weeks to show improvement of symptoms.
Xiidra as a brand is protected by fifteen patents under Novartis. It was eligible for patent challenges on July 11, 2020. Based on its patents and regulatory protections it may take 8 years or more before a generic version will be approved.
DISCLAIMER: The information provided here is for informational purposes only and is not intended to replace the medical advice provided by a certified medical professional. You require your doctor's approval prior to buying or using prescription drugs sold here. We do have a pharmacist on staff if your doctor is unavailable to provide medical advice when you buy Xiidra online. Do not use the information here to ignore or contradict advice provided by a licensed medical professional. Always seek medical advice if you have any questions or concerns about this medication.